Christella E. Widjaja
Pfizer (United States)(US)Columbia University Irving Medical Center(US)
Publications by Year
Research Areas
Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Ubiquitin and proteasome pathways, Single-cell and spatial transcriptomics
Most-Cited Works
- → Heterogenous Populations of Tissue-Resident CD8+ T Cells Are Generated in Response to Infection and Malignancy(2020)282 cited
- → Early transcriptional and epigenetic regulation of CD8+ T cell differentiation revealed by single-cell RNA sequencing(2017)247 cited
- → Early precursors and molecular determinants of tissue-resident memory CD8 + T lymphocytes revealed by single-cell RNA sequencing(2020)215 cited
- → Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial(2018)69 cited
- → Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specification(2017)50 cited
- → The long noncoding RNA Malat1 regulates CD8+ T cell differentiation by mediating epigenetic repression(2022)44 cited
- → Immunodeficiency and Autoimmune Enterocolopathy Linked to NFAT5 Haploinsufficiency(2015)39 cited
- → Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition(2016)35 cited
- → The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients(2022)28 cited
- → Molecular determinants and heterogeneity of tissue-resident memory CD8 + T lymphocytes revealed by single-cell RNA sequencing(2020)7 cited